Vassiliki Papadimitrakopoulou
Medical Oncology · Houston, TXNPI 1144311101
Payments from drug & device makers
Across 101 payments — averaging $27,884 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1.3M
- Novartis$892K
- Merck$233K
- Clovis Oncology, Inc.$169K
- Foundation Medicine, Inc.$150K
- Incyte Corporation$35K
- plus $76K from 8 others
Across 1 payment — averaging $31,800 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Foundation Medicine, Inc.$32K
What the payments were for
- Consulting fees$22,98756%
- Speaking & faculty fees$11,06627%
- Travel & lodging$5,66614%
- Food & beverage$1,2223%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $1,261,515 |
| Novartis | 3 | $891,623 |
| Merck | 7 | $233,334 |
| Clovis Oncology, Inc. | 11 | $168,530 |
| Foundation Medicine, Inc. | 12 | $150,000 |
| Incyte Corporation | 6 | $35,451 |
| F. Hoffmann-la Roche AG | 10 | $34,485 |
| Janssen Research & Development, LLC | 2 | $27,254 |
| Bayer | 6 | $6,237 |
| Astrazeneca UK Limited | 4 | $3,040 |
| Janssen Global Services, LLC | 1 | $1,550 |
| Pfizer | 3 | $1,260 |
| Eli Lilly | 9 | $1,035 |
| Genentech USA, Inc. | 3 | $933 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,816,247 in reported general payments places this provider in the 80th percentile of 495 medical oncology providers in Texas.
Other medical oncology in Houston
- Hagop KantarjianHouston$100.5M
- Timothy YapHouston$56.7M
- Yasir ElaminHouston$41.3M
- David HongHouston$31.6M
- Guillermo Garcia-ManeroHouston$31.6M
- Jason WestinHouston$30.8M
- Lucia MasarovaHouston$29.7M
- Jordi Rodon AhnertHouston$28.1M
- Sarina Piha PaulHouston$26M
- Jenny ChangHouston$17.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.